期刊文献+

禽致病性大肠杆菌(APEC)菌蜕的制备研究 被引量:11

Generation of avian pathogenic E.coli ghosts
下载PDF
导出
摘要 菌蜕是通过PhiX174噬菌体溶菌基因E的可调控表达而形成的、缺少细胞浆和核酸且无繁殖能力的革兰氏阴性细菌菌体。这种非变性的灭活方式使菌蜕完好保留了细菌的各种抗原成分和免疫黏附分子,具有优良的免疫原性和固有的免疫佐剂性质以及免疫系统靶向性质。菌蜕的这些生物学特点使其在作为新型非变性灭活菌苗、作为递呈异源抗原的重组疫苗以及作为DNA疫苗甚至药物的载体方面都显现出巨大的研究开发前景。本研究成功构建了热敏诱导、pR、pL串联双启动子表达E基因的、具有不同抗性标记和复制起点的系列溶菌载体,比国外用pR或pL单启动子的溶茵载体在K-12株大肠杆菌(如XL1-blue)的溶茵效率高一个指数级。本研究还成功制备出禽致病性大肠杆菌(Avian pathogenic E.coli,APEC)野毒株的菌蜕,为进一步进行菌蜕疫苗的开发研究奠定了技术基础。 Bacterial ghosts are non-living Gram-negative bacterial cell envelopes devoid of cytoplasmic contents, produced by controlled artificial expression of bacteriophage PhiX174 gene E and subsequent lysis of bacterial cells. This non-denaturing inactivation method keeps antigenic determinants and adhesive molecules of bacteria intact, and as a result, bacterial ghosts are excellent candidates of recombinant vaccines presenting heterologous antigens and delivering vehicles of DNA vaccine or drugs. In this study, we constructed a series of lysis vectors harboring different antibiotic markers and replication origins to express lysis gene E under the control of tandem pR and pL double promoters. The lysis and inactivation efficiency of the lysis vectors in E.coli K-12 strain was up to 1 order of magnitude higher than that of previously reported vectors in which only single promoter ofpR or pL was used. Ghosts of a wild strain of avian pathogenic E.coli (APEC) were successfully generated with one of the lysis vectors, which laid foundation for future development of bacterial ghost vaccines.
出处 《中国预防兽医学报》 CAS CSCD 北大核心 2007年第6期423-427,共5页 Chinese Journal of Preventive Veterinary Medicine
基金 重庆市自然基金重点项目(CSTC 2007BA1014)
关键词 菌蜕 禽致病性大肠杆菌 灭活疫苗 bacterial ghost avian pathogenic E.coli inactivated vaccine
  • 相关文献

参考文献9

  • 1Blasi U,Henrich B,Lubitz W,et al.Lysis of Escherichia coli by cloned gene E depends on its expression[J].J Gen Microbiol,1985,131:1107-1114.
  • 2Lubitz W,Pugsley A P.Changes in host cell phospholipid composition of PhiX 174 gene E product[J].FEMS Microbiol Lett,1985,30:171-175.
  • 3Szostak M P,Hensel A,Eko F O,et al.Bacterial ghosts:nonliving candidate vaccines[J].J Biotechnol,1996,44:161-170.
  • 4Marchart J,Dropmann G,Lechleitner S,et al.Pasteurella multocida-and Pasteurella haemolytica-ghosts:new vaccine candidates[J].Vaccine,2003,21:3988-3997.
  • 5Hensel A,Huter V,Katinger A,et al.Intramuscular Immunization with Genetically Inactivated (ghosts) Actinobacillus pleuropneumoniae Serotype 9 Protects Pigs against Homologous Aerosol Challenge and Prevents Carrier State[J].Vaccine,2000,18:2945-2955.
  • 6Mayr U B,Hailer C,Haidinger W,et al.Bacterial ghosts as an oral vaccine:a single dose of Escherichia coli O157:H7 bacterial ghosts protects mice against lethal challenge[J].Infection and Immunity,2005,73:4810-4817.
  • 7王宁,曾韦锟,郭刚,邹全明.大肠杆菌“细菌膜影”的制备与初步研究[J].解放军医学杂志,2005,30(3):226-228. 被引量:2
  • 8Sambrook J,Fritsch E F,Maniatis T.Molecular Cloning:a Laboratory Manual[M].2nd ed.Cold Spring Harbor,NY:Cold Spring Harbor Laboratory,1989.
  • 9Haidinger W,Szostak M P,Beisker W,et al.Green fluorescent protein (GFP)-dependent separation of bacterial ghosts from intact ceils by FACS[J].Cytometry,2001,44:106-112.

二级参考文献6

  • 1Szostak MP, Hensel A, Eko FO et al. Bacterial ghosts: non-living candidate vaccines. J Biotechnol,1996,44(1-3):161s.
  • 2Panthel K, Jechlinger W, Matis A et al. Generation of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates .Infect Immun,2003,71(1):109.
  • 3Jalava K, Eko FO, Riedmann E et al. Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery. Expert Rev Vaccines, 2003,2(1):45.
  • 4Jalava K, Hensel A, Szostak MP et al. Bacterial ghosts as vaccine candidates for veterinary applications. J Control Release,2002, 85(1-3): 17.
  • 5Mader HJ, Szostak MP, Hensel A et al. Endotoxicity does not limit the use of bacterial ghosts as candidate vaccines. Vaccine,1997,15(2):195.
  • 6Tabrizi CA, Walcher P, Mayr UB et al. Bacterial ghosts-biological particles as delivery systems for antigens, nucleic acids and drugs. Curr Opin Biotechnol, 2004,15(6):530.

共引文献1

同被引文献139

  • 1王宁,曾韦锟,郭刚,邹全明.大肠杆菌“细菌膜影”的制备与初步研究[J].解放军医学杂志,2005,30(3):226-228. 被引量:2
  • 2张瑞平,张兆山.细菌菌蜕作为新颖药物递送体系的研究进展[J].生物化学与生物物理进展,2006,33(7):622-626. 被引量:15
  • 3朴东日,赵鸿雁,李兰玉,崔步云,李元凯.从北京某地分离的2株犬种布氏菌的鉴定报告[J].中国地方病防治,2006,21(5):263-264. 被引量:10
  • 4密金玲,聂奎.细菌菌蜕疫苗的研究进展[J].中国人兽共患病学报,2007,23(5):504-506. 被引量:4
  • 5Callaway TR,Carr MA,Edrington TS,et al.Diet,Escherichia coli O157:H7,and cattle:a review after 10 years[J].Curr Issues Mol Biol,2009,11(2):67-79.
  • 6Liu J,Sun Y,Feng S,et al.Towards an attenuated enterohemorrhagic Escherichia coli O157:H7 vaccine characterized by a deleted ler gene and containing apathogenic Shiga toxins[J].Vaccine,2009,27(43):5929-5935.
  • 7Szostak MP,Hensel A,Eko FO,et al.Bacterial ghosts:non-living candidate vaccines[J].J Biotechnol,1996,44(1-3):161-170.
  • 8Witte A,Lubitz W.Biochemical characterization of phi X174-protein-E-mediated lysis of Escherichia coli[J].Eur J Biochem,1989,180(2):393-398.
  • 9Riedmann EM,Kyd JM,Cripps AW,et al.Bacterial ghosts as adjuvant particles[J].Expert Rev Vaccines,2007,6(2):241-253.
  • 10Mayr UB,Walcher P,Azimpour C,et al.Bacterial ghosts as antigen delivery vehicles[J].Adv Drug Deliv Rev,2005,57(9):1381-1391.

引证文献11

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部